Table 1.
ligand | RH–FCS (nm) | RH–DLS (nm) | ζ-potential (mV) | abs./em. (nm) | QY % |
cysteaminea | 6.3 ± 0.4 | 5.0 ± 0.5 | +29 ± 4b | 592/604 | 55 ± 2 |
DPAa | 6.1 ± 0.1 | 4.5 ± 0.5 | −27 ± 2 | 592/604 | 52 ± 2 |
DHLA | 4.8 ± 0.2 | 4.1 ± 0.7 | −31 ± 4 | 584/604 | 8 ± 2 |
polymerc | 9.3 ± 0.2 | 8.8 ± 1.7 | −27 ± 2 | 570/586 | 69 ± 3 |
aPrepared from commercial core/shell QDs (QD ITK 605, Invitrogen); bin milliQ water; ccommercial QDs (QD ITK 585, Invitrogen) with carboxyl surface functionalization.